11/17/15 17:15 | 11/13/15 | EBS | Emergent Biosolutions Inc. | DE | Health | Drug | Pharmaceutical Preparations | Labinger Barry | MD | O | EVP,Bios | S | -123 | 36.50 | 13 | -3 | -12 | 25 | D | 71 | 49 | 14 | 6 | 27 | 12 | 6 | 0 | 2 | 4 | 5 | 0 | 15 | -17 |
11/13/15 16:49 | 11/11/15 | EBS | Emergent Biosolutions Inc. | DE | Health | Drug | Pharmaceutical Preparations | Labinger Barry | MD | O | EVP,Bios | S.dm | -1,288 | 35.64 | 12 | -36 | -56 | 29 | D | 70 | 45 | 18 | 6 | 26 | 20 | 8 | 1 | -2 | 1 | -1 | 1 | 12 | -16 |
11/13/15 16:49 | 11/11/15 | EBS | Emergent Biosolutions Inc. | DE | Health | Drug | Pharmaceutical Preparations | Labinger Barry | MD | O | EVP,Bios | M.dm | 686 | 23.21 | 12 | 30 | | 29 | D | 70 | 45 | 18 | 6 | 26 | 20 | 8 | 1 | -2 | 1 | -1 | 1 | 12 | -16 |
7/26/12 11:09 | 7/25/12 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Labinger Barry | MD | O | EVP,CCO | M.d | 59 | 1.86 | 0 | 31 | 171 | 50 | D | | | | | | | | | | | | | | |
7/27/11 12:55 | 7/26/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Labinger Barry | MD | O | EVP,CCO | M.d | 174 | 9.47 | 33 | 18 | New | 18 | D | 52 | -17 | -13 | -27 | -18 | -14 | -8 | -8 | -3 | -11 | -38 | -36 | -53 | |
5/4/11 14:57 | 5/2/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Labinger Barry | MD | O | EVP,CCO | M.d | 36 | 4.92 | 33 | 7 | | 0 | D | 999 | 4 | 7 | 16 | 5 | -3 | -2 | -4 | -1 | -2 | -5 | -34 | -64 | |
5/4/11 14:57 | 5/2/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Labinger Barry | MD | O | EVP,CCO | S.d | -220 | 30.00 | 33 | -7 | -100 | 0 | D | 999 | 4 | 7 | 16 | 5 | -3 | -2 | -4 | -1 | -2 | -5 | -34 | -64 | |
4/29/11 15:37 | 4/28/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Labinger Barry | MD | O | EVP,CCO | M.d | 73 | 1.82 | 33 | 40 | | 0 | D | 999 | 4 | 11 | 20 | 9 | 7 | 4 | 2 | 0 | -7 | -9 | -32 | -67 | |
4/29/11 15:37 | 4/28/11 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Labinger Barry | MD | O | EVP,CCO | S.d | -1,199 | 30.00 | 33 | -40 | -100 | 0 | D | 999 | 4 | 11 | 20 | 9 | 7 | 4 | 2 | 0 | -7 | -9 | -32 | -67 | |
9/2/10 14:38 | 9/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | M.d | 246 | 4.92 | 33 | 50 | | 0 | D | 293 | 59 | -4 | 12 | 18 | 12 | 8 | 1 | 1 | 2 | -1 | -16 | -12 | -56 |
9/2/10 14:38 | 9/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | S.d | -1,501 | 30.02 | 33 | -50 | -100 | 0 | D | 293 | 59 | -4 | 12 | 18 | 12 | 8 | 1 | 1 | 2 | -1 | -16 | -12 | -56 |
8/30/10 16:31 | 8/26/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | M.dm | 143 | 4.92 | 33 | 29 | | 0 | D | 316 | 55 | -2 | 19 | 22 | 6 | 11 | 9 | 0 | 4 | -1 | -14 | -13 | -56 |
8/30/10 16:31 | 8/26/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | S.dm | -831 | 28.52 | 33 | -29 | -100 | 0 | D | 316 | 55 | -2 | 19 | 22 | 6 | 11 | 9 | 0 | 4 | -1 | -14 | -13 | -56 |
7/27/10 15:06 | 7/26/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | M.d | 11 | 0.5200 | 33 | 22 | | 0 | D | 279 | 80 | -3 | -7 | 1 | 21 | 4 | 9 | -2 | 0 | 3 | 0 | -7 | -20 |
7/27/10 15:06 | 7/26/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | S.d | -592 | 27.05 | 33 | -22 | -100 | 0 | D | 279 | 80 | -3 | -7 | 1 | 21 | 4 | 9 | -2 | 0 | 3 | 0 | -7 | -20 |
12/1/09 12:10 | 11/30/09 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | M.d | 13 | 0.5200 | 33 | 25 | | 0 | D | 166 | 999 | 958 | 41 | 33 | -2 | 0 | 0 | -3 | -1 | 11 | 12 | -6 | -12 |
12/1/09 12:10 | 11/30/09 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | S.d | -1,908 | 27.37 | 33 | -70 | -100 | 0 | D | 166 | 999 | 958 | 41 | 33 | -2 | 0 | 0 | -3 | -1 | 11 | 12 | -6 | -12 |
8/18/06 14:35 | 8/16/06 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Labinger Barry | MD | O | EVP,CCO | S | -52 | 9.79 | 21 | -5 | -11 | 45 | D | -4 | -20 | -19 | -1 | -2 | 3 | 3 | 7 | 1 | 0 | 18 | 29 | 13 | -17 |